Bal Pharma Ltd. (BALPHARMA)
Market Open
15 Oct, 09:59 AM
XNSE XNSE Primary MSE ₹
97. 74
-0.7
-0.7111%
₹
2.1B Market Cap
- P/E Ratio
4.8% Div Yield
6,604 Volume
- Eps
₹ 98.44
Previous Close Want to track BALPHARMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bal Pharma Ltd. (BALPHARMA) Statistics
Valuation metrics
Market Cap 2.1B
Enterprise value 1.48B
Trailing P/E (ttm) 20.5
Forward P/E -
PEG ratio -3.31
Price/Sales (ttm) 0.44
Price/Book (mrq) 1.8
Enterprise Value/Revenue 0.44
Enterprise Value/EBITDA 4.27
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 29.27K
Average volume (90 days) 73.34K
Price summary
52-Week low 60
52-Week high 124.6
Beta -
50-Day moving average 98.46
200-Day moving average 86.4
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.2
Trailing annual dividend yield 0.0129%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 10 Oct 2025
Ex-Dividend Date 18 Sep 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.02%
Operating margin 0.07%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.09%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 210.04
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 4.53
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.84
Total debt (mrq) -
Total Debt/Equity (mrq) 1.94
Current ratio (mrq) 1.05%
Book value per share (mrq) 51.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
